Concepedia

Michelle Kelleher

MK

15

Publications

1.2K

Citations

14

H-Index

1990

Active since

Affiliations

Oxford BioMedica (United Kingdom)(Current)

Royal Statistical Society

Walter and Eliza Hall Institute of Medical Research

Centre National de la Recherche Scientifique

Inserm

Michelle Kelleher is an author at Oxford BioMedica (United Kingdom) specializing in medicine, immunology, and immunotherapy.

Top concepts

Publications per year

1990–2019

15

Publications

15

Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial

Stéphane Palfi, Jean Marc Gurruchaga, G. Ralph et al. · The Lancet · 2014 · 432 citations

, , +11

Lentiviral Vector Gene Transfer of Endostatin/Angiostatin for Macular Degeneration (GEM) Study

Peter A. Campochiaro, Andreas Lauer, Elliott H. Sohn et al. · Human Gene Therapy · 2016 · 179 citations · Full text

Transduction of Photoreceptors With Equine Infectious Anemia Virus Lentiviral Vectors: Safety and Biodistribution of StarGen for Stargardt Disease

Katie Binley, Peter Widdowson, Julie Loader et al. · Investigative Ophthalmology & Visual Science · 2013 · 108 citations · Full text

EIAV-Based Retinal Gene Therapy in the shaker1 Mouse Model for Usher Syndrome Type 1B: Development of UshStat

Marisa Zallocchi, Katie Binley, Yatish Lad et al. · PLoS ONE · 2014 · 102 citations · Full text

, , +17

Safety and Biodistribution of an Equine Infectious Anemia Virus-Based Gene Therapy, RetinoStat <sup>®</sup> , for Age-Related Macular Degeneration

Katie Binley, Peter Widdowson, Michelle Kelleher et al. · Human Gene Therapy · 2012 · 63 citations

Rows per page

1–5 of 15